Preparing a formal complaint submission to the U.S. FDA
Budget: $30 – $250 USD
I need to turn a clear set of laboratory findings into a professionally structured FDA complaint against a dental cement that is marketed in the United States as a Class II medical device. The lab report I have in hand shows ingredients that do not match the manufacturer’s declaration, pointing to a likely misbranding violation under 21 CFR Part 801. My priority is the actual drafting of the submission, so I am counting on you to translate the technical evidence into a persuasive, regulation-aligned document ready for CDRH intake.
While the report and product dossier will be supplied, I welcome your concise review of them only insofar as it sharpens the narrative. What I really need is a complaint that not only lays out the misbranding evidence but also proposes specific corrective actions the FDA could require—recalls, relabeling, or post-market surveillance—so the Agency immediately sees a roadmap to resolution.
To strengthen the argument I can provide a comparative analysis of competing cements that are properly labeled; please weave those points in where they reinforce the misbranding claim.
Deliverables I will look for:
• A finished FDA complaint letter (Word and PDF) citing applicable sections of the FD&C Act and 21 CFR.
• An evidence appendix that links each lab finding to the corresponding regulatory breach.
• A succinct section outlining possible FDA corrective measures, supported by precedent where available.
Acceptance will be based on regulatory accuracy, logical flow, and readiness for immediate electronic submission through the FDA’s reporting portal.
While the report and product dossier will be supplied, I welcome your concise review of them only insofar as it sharpens the narrative. What I really need is a complaint that not only lays out the misbranding evidence but also proposes specific corrective actions the FDA could require—recalls, relabeling, or post-market surveillance—so the Agency immediately sees a roadmap to resolution.
To strengthen the argument I can provide a comparative analysis of competing cements that are properly labeled; please weave those points in where they reinforce the misbranding claim.
Deliverables I will look for:
• A finished FDA complaint letter (Word and PDF) citing applicable sections of the FD&C Act and 21 CFR.
• An evidence appendix that links each lab finding to the corresponding regulatory breach.
• A succinct section outlining possible FDA corrective measures, supported by precedent where available.
Acceptance will be based on regulatory accuracy, logical flow, and readiness for immediate electronic submission through the FDA’s reporting portal.